Lean Mass and Musculoskeletal Preservation in GLP-1-Based Obesity Treatment: Nutrition, Exercise, Supplementation, and Monitoring Strategies

<b>Background/Objectives:</b> GLP-1-based obesity pharmacotherapy has shifted clinical attention from the magnitude of weight loss to the quality of weight loss. This review evaluates whether body composition changes during treatment with GLP-1-based agents represent clinically meaningful muscle los...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Roko Šantić, Lovre Martinović, Nikola Pavlović, Doris Rušić, Marko Kumrić, Dinko Martinović, Tina Tičinović Kurir, Joško Božić
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2026-05-01
Edice:	Metabolites
Témata:	GLP-1 receptor agonists semaglutide tirzepatide skeletal muscle mass obesity protein intake
On-line přístup:	https://www.mdpi.com/2218-1989/16/6/364
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!